EP Biocomposites Ltd

EP Biocomposites Limited announced strong audited financial results for the financial year ended March 31, 2026. For FY26, Revenue from Operations grew 13.60% YoY to ₹1,363.98 Lakh. EBITDA increased by 26.23% YoY to ₹237.83 Lakh, with margins at 17.44%. Profit After Tax (PAT) surged by 41.4% YoY to ₹145.83 Lakh, achieving PAT margins of 10.69%. Basic EPS stood at ₹8.67. Key highlights include net worth crossing ₹12 crore, ROI at 14%, and ROCE improving to 16%. The company successfully utilized IPO proceeds for capacity expansion, working capital, and business growth, while also strengthening its balance sheet through partial debt repayment. Management expressed optimism for future growth, emphasizing sustainable manufacturing and operational excellence.

EP Biocomposites Ltd has announced its financial results for the year ended March 31, 2026. The Board of Directors approved the audited financial statements in their meeting held on May 26, 2026. Revenue from operations stood at ₹1,363.98 lakhs, with total income at ₹1,378.10 lakhs. The company's website, www.epbiocomposites.com, also disseminates these results.

EP Biocomposites Ltd has released its audited financial results for the year ended March 31, 2026. The Board of Directors approved the financial statements in their meeting held on May 26, 2026. The company's revenue from operations stood at ₹1,363.98 lakhs, with total income reaching ₹1,378.10 lakhs. The Board Meeting commenced at 04.00 P.M. and concluded at 5.30 P.M.

EP Biocomposites Ltd has scheduled a Board of Directors meeting on May 26, 2026, to approve the draft audited financial statements for the year ended March 31, 2026. The meeting will be held at the company's office in Panaji, Goa. The trading window for dealing in the company's securities is currently closed and will reopen 48 hours after the conclusion of the board meeting.

EP Biocomposites Ltd has announced the closure of its trading window for the earnings release of the financial year ending March 31, 2026. This closure is in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015. The trading window will reopen after 48 hours of the dissemination of the financial results. The date of the Board meeting for approval of the financial results for the year ended March 31, 2026, will be intimated in due course.

EP Biocomposites Limited, a leading provider of advanced wastewater treatment solutions, has entered into a strategic agreement with the Indian Institute of Science (IISc), Bengaluru. The collaboration aims to strengthen the company's technical and research-backed capabilities in advanced wastewater treatment systems, focusing on innovative non-biological treatment technologies for wastewater recycling. IISc will provide expert technical consultancy, design review, and process optimization support. This engagement is expected to enhance process efficiency, system reliability, and compliance with evolving environmental regulations. The strategic step will enable EP Biocomposites Limited to introduce unique non-biological wastewater treatment solutions, differentiating its offerings in the market while supporting sustainable water management practices. The collaboration aligns with the company's long-term strategy of delivering environmentally responsible and technology-driven solutions across industrial and municipal wastewater treatment applications.

EP Biocomposites Ltd has entered into an agreement with the Indian Institute of Science (IISc), Bengaluru, to strengthen its technical and research-backed capabilities in the area of advanced wastewater treatment solutions. The collaboration aims to enhance process efficiency, system reliability, and compliance with evolving environmental regulations through expert technical consultancy and design inputs. This engagement will help EP Biocomposites Ltd offer unique non-biological treatment for wastewater recycling, enabling the Company to differentiate its offerings, support sustainable water management practices, and expand its presence in industrial and municipal wastewater treatment applications. The agreement is for technical consultancy, design review, and expert inputs relating to non-biological wastewater treatment systems.

EP Biocomposites Ltd has received a work order from Goa Tourism Development Corporation Ltd for the manufacture, supply, transportation, and installation of 1,000 units of Model IV Premium Cast Iron Benches, valued at INR 2.15 crores (excluding 18% GST). The order is a repeat order and is in line with the company's practice of delivering projects in a time-bound manner. The proposed installation of the benches aims to enhance public seating infrastructure, improve visitor convenience, and provide durable, long-term amenities at tourism and public locations across the State of Goa.

EP Biocomposites Ltd has announced its unaudited financial results for the half year ended September 30, 2025. The results show revenue from operations, profit before tax, and earnings per equity share. The company's statement of assets and liabilities as of September 30, 2025, is also provided.

EP Biocomposites Ltd has announced its financial results for the half year ended September 30, 2025. The company's revenue from operations, profit before tax, and earnings per equity share have increased compared to the same period last year. The company's standalone statement of assets and liabilities as of September 30, 2025, and statement of profit and loss for the half year ended September 30, 2025, have also been released.